源飞宠物 20250701 摘要 元飞宠物早期通过咬胶产品起家，后拓展至宠物牵引用具，与国际零售 巨头建立合作，奠定海外业务基础。目前海外代工业务扎实，约 70%出 口订单面向美国，柬埔寨产能有效降低关税影响。 自 2023 年起，元飞宠物积极布局国内市场，推出皮卡普、哈乐威、传 奇精灵等自主品牌，并组建专业团队，优化供应链和品牌运营，加速品 牌化进程。2025 年 Q1 销售费用同比增近 100%，自主品牌投入决心 强烈。 全球宠物市场持续增长，中国市场规模 2024 年达 3,002 亿元，复合增 速超 10%，宠物食品规模约 1,500 亿元，同样保持高速增长。高端国 产品牌如弗列加特、蓝氏等在电商平台崭露头角，本土企业在渠道和营 销方面优势明显。 2025 年第一季度，元飞宠物毛利率增速放缓，利润下滑，主要受低毛 利率品类占比提升及国内业务费用前置影响。管理费用因品牌拓展人员 增加而上升，短期业绩承压。 Q&A 元飞宠物的发展历程是怎样的？ 元飞宠物成立于 2004 年，专注于宠物用品和零食的研发、生产和销售。公司 发展可以分为三个阶段：第一阶段（2004-2014 年），公司在浙江省温州市 平阳县成 ...

Investment Rating - The investment rating for the company is "Buy-A" with a target price of 35.57 CNY, maintaining the rating [4][8]. Core Views - The company has shown strong revenue growth, achieving 9.95 billion CNY in Q1 2025, a year-on-year increase of 30.10%, and a net profit of 1.31 billion CNY, up 27.27% year-on-year [1][4]. - The company is focusing on expanding its market share through product structure optimization and channel expansion, particularly in e-commerce [4][8]. - The company’s gross margin slightly decreased to 53.32%, while the net margin was 13.12%, reflecting a minor decline [3][4]. Summary by Sections Revenue and Profitability - In Q1 2025, the company reported a revenue of 9.95 billion CNY, a 30.10% increase year-on-year, and a net profit of 1.31 billion CNY, which is a 27.27% increase year-on-year [1]. - The company’s gross margin was 53.32%, down 1.04 percentage points year-on-year, and the net margin was 13.12%, down 0.29 percentage points year-on-year [3]. Channel Performance - The e-commerce channel generated 3.22 billion CNY in revenue in Q1 2025, growing 8.6% year-on-year, while core provinces saw a 26.7% increase and peripheral provinces experienced a remarkable 125.1% growth [2]. - The company is shifting its marketing strategy to a multi-channel approach, increasing investments in platforms like Tmall, Pinduoduo, and Xiaohongshu, in addition to Douyin [2]. Future Projections - The company is projected to achieve revenues of 43.20 billion CNY, 55.09 billion CNY, and 70.31 billion CNY for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 32.76%, 27.51%, and 27.62% [4][9]. - Net profits are expected to reach 3.72 billion CNY, 4.74 billion CNY, and 6.45 billion CNY for the same years, with growth rates of 29.46%, 27.14%, and 36.02% [4][9].

Core Viewpoint - The company reported strong financial performance in Q1 2025, with significant year-on-year growth in revenue and net profit, despite facing challenges from public sentiment issues and cash flow disruptions due to promotional activities [1][4]. Financial Performance - The company achieved revenue of 9.95 billion, a year-on-year increase of 30.10% - The net profit attributable to shareholders was 1.31 billion, up 27.27% year-on-year - The net profit after deducting non-recurring items was 1.29 billion, reflecting a 32.40% increase year-on-year [1]. Product and Market Performance - The company focused on sanitary napkin products, with revenue from the Freedom Point sanitary napkin line reaching 9.52 billion, a 35.8% increase year-on-year - High-end product revenue share continued to rise, while offline channel revenue grew by 49.0% to 6.50 billion, with outer provinces seeing a 125.1% increase [2]. - E-commerce channel revenue was 3.22 billion, reflecting an 8.6% year-on-year growth [2]. Cost and Profitability Analysis - The overall gross margin decreased by 1.04 percentage points to 53.32% due to changes in channel and product structure - Sales expenses increased by 28.5% year-on-year, but the sales expense ratio was diluted due to rapid revenue growth, with net profit margin at 13.12%, down 0.29 percentage points [3]. Cash Flow and Operational Insights - Operating cash flow net amount was 0.07 billion, down 92.92% year-on-year, primarily due to increased accounts receivable from promotional activities - The company is managing the aftermath of the public sentiment issue and is expected to recover its reputation over time, which may lead to a more standardized development in the sanitary napkin industry [4]. Future Outlook - The company anticipates continued growth in the probiotic series, which is expected to drive e-commerce and outer market expansion - Revenue projections for 2025-2027 are 42.30 billion, 54.02 billion, and 67.39 billion, with year-on-year growth rates of 29.99%, 27.71%, and 24.74% respectively - Net profit forecasts for the same period are 3.68 billion, 4.52 billion, and 5.58 billion, with corresponding growth rates of 28.02%, 22.67%, and 23.47% [5].